Diagnosis and management of noninfectious pediatric uveitis

International Ophthalmology Clinics

Volumn 51, Issue 1, 2011, Pages 129-145

  Kim, Stephen Jae ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALKYLATING AGENT; ANTIMETABOLITE; AZATHIOPRINE; BETAMETHASONE SODIUM PHOSPHATE; CALCINEURIN INHIBITOR; CERTOLIZUMAB PEGOL; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; FLUOCINOLONE ACETONIDE; FOLIC ACID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; KETOROLAC; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE ACETATE; PREDNISOLONE SODIUM PHOSPHATE; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RIMEXOLONE; TACROLIMUS; TOLMETIN; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR INHIBITOR; UNINDEXED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BEHCET DISEASE; BONE NECROSIS; CATARACT; CATARACT EXTRACTION; CHILDHOOD DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPIDEMIOLOGICAL DATA; EYE DISEASE; EYE INFLAMMATION; GASTROINTESTINAL SYMPTOM; GLAUCOMA; GLAUCOMA SURGERY; GONAD ATROPHY; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPOTONY MACULOPATHY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; INTERSTITIAL NEPHRITIS; INTRAOCULAR HYPERTENSION; IRIDOCYCLITIS; JUVENILE RHEUMATOID ARTHRITIS; KERATOPATHY; LEUKOPENIA; LINEAR GROWTH; LUNG TUBERCULOSIS; MASQUERADE SYNDROME; MONOTHERAPY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEOPLASM; NONHUMAN; OSTEOPOROSIS; PATIENT COMPLIANCE; PEDIATRIC ADVANCED LIFE SUPPORT; PHAKOMATOSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA EDEMA; RETINOBLASTOMA; RISK FACTOR; SARCOIDOSIS; SIDE EFFECT; SLOW RELEASE FORMULATION; SYSTEMIC DISEASE; T LYMPHOCYTE; TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS; UVEITIS; WEIGHT GAIN;

ANTI-INFLAMMATORY AGENTS; CHILD; CHRONIC DISEASE; HUMANS; IMMUNOSUPPRESSION; PROGNOSIS; UVEITIS;

EID: 78650852205     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e318200e01b     Document Type: Article

References (95)

1. Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001;45:252-257.
2. Edelsten C, Reddy MA, Stanford MR, et al. Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol. 2003;135:676-680.
3. Paivonsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand. 2000;78:84-88.
4. Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis. Arch Ophthalmol. 1962;68:100-112.
5. Perkins ES. Pattern of uveitis in children. Br J Ophthalmol. 1966;50:169-185.
6. Holland GN, Stiehm ER. Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol. 2003;135:867-878.
7. Zierhut M, Michels H, Stubiger N, et al. Uveitis in children. Int Ophthalmol Clin. 2005; 45:135-156.
8. Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology. 1984;91:1247-1252.
9. Tugal-Tutkun I, Havrlikova K, Power WJ, et al. Changing patterns in uveitis of childhood. Ophthalmology. 1996;103:375-383.
10. Levy-Clarke GA, Nussenblatt RB, Smith JA. Management of chronic pediatric uveitis. Curr Opin Ophthalmol. 2005;16:281-288.
11. BenEzra D, Cohen E, Maftzir G. Patterns of intraocular inflammation in children. Bull Soc Belge Ophthalmol. 2001;279:35-38.
12. Mackensen F, Billing H. Tubulointerstitial nephritis and uveitis syndrome. Curr Opin Ophthalmol. 2009;20:525-531.
13. Perrin L, Letierce A, Guitton C, et al. Comparative study of complete versus incomplete Kawasaki disease in 59 pediatric patients. Joint Bone Spine. 2009;76: 481-485.
14. Cunningham ET. Uveitis in children. Ocul Immunol Inflamm. 2000;8:251-261.
15. Okada AA, Foster CS. Posterior uveitis in the pediatric population. Int Ophthalmol Clin. 1992;32:121-152.
16. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80: 332-336.
17. Kimura SJ, Hogan MJ. Uveitis in children: analysis of 274 cases. Trans Am Ophthalmol Soc. 1964;62:173-192.
18. Pivetti-Pezzi P. Uveitis in children. Eur J Ophthalmol. 1996;6:293-298.
19. Petty RE. Classification of childhood arthritis: 1897-1997. Rev Rhum Engl Ed. 1997;64:161S-162S.
20. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390-392.
21. Cabral DA, Oen KG, Petty RE. SEA syndrome revisited: a long-term follow-up of children with a syndrome of enthesopathy and arthropathy. J Rheumatol. 1992;19: 1282-1285.
22. Petty RE, Smith JR, Rosenbaum JT. Arthritis and uveitis in children. A pediatric rheumatology perspective. Am J Ophthalmol. 2003;135:879-884.
23. Kanski JJ. Juvenile arthritis and uveitis. Surv Ophthalmol. 1990;34:253-267.
24. Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987;94:1242-1248.
25. Dana MR, Merayo-Lloves J, Schaumberg DA, et al. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997;104:236-244.
26. Ceisler EJ, Foster CS. Juvenile rheumatoid arthritis and uveitis: minimizing the blinding complications. Int Ophthalmol Clin. 1996;36:91-107.
27. Chalom EC, Goldsmith DP, Koehler MA, et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol. 1997; 24:2031-2034.
28. Woreta F, Thorne JE, Jabs DA, et al. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143:647-655.
29. Rosenberg AM, Oen KG. The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum. 1986;29:797-800.
30. American Academy of Pediatrics. Section on Rheumatology and Section on Ophthalmology. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 1993;92:295-296.
31. Thorne JE,Woreta F, Kedhar SR, et al. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007; 143:840-846.
32. Cimaz R, Ansell BM. Sarcoidosis in the pediatric age. Clin Exp Rheumatol. 2002; 28:309-312.
33. Shetty AK, Gedalia A. Sarcoidosis in children. Curr Probl Pediatr. 2000;30:153-176.
34. Jabs DA, Jouk JL, Bias WB, et al. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med. 1985;78:801-804.
35. Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107: 689-693.
36. Latkany PA, Jabs DA, Smith JR, et al. Multifocal choroiditis in patients with familiar juvenile systemic granulomatosis. Am J Ophthalmol. 2002;134:897-904.
37. Dobrin RS, Vernier RL, Fish FJ. Acute eosinophilic interstitial nephritis and renal failure with bone marrow-lymph node granulomas and anterior uveitis. Am J Med. 1975;596:325-333.
38. Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol. 2001;46:195-208.
39. Grossniklaus HE, Dhaliwal RS, Martin DF. Diffuse anterior retinoblastoma. Retina. 1998;18:238-241.
40. Mietz H, Hutton WL, Font RL. Unilateral retinoblastoma in an adult: report of a case and review of the literature. Ophthalmology. 1997;104:43-47.
41. Zamir E, Wang RC, Krishnakumar S, et al. Juvenile xanthogranuloma masqerading as pediatric chornic uveitis: a clinicopathological study. Surv Ophthalmol. 2001; 46:164-171.
42. Cho AS, Holland GN, Glasgow BJ, et al. Ocular involvement in patients with posttransplant lymphoproliferative disorder. Arch Ophthalmol. 2001;119:183-189.
43. Kim SJ, Flach AJ, Jampol LE. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010;55:108-133.
44. Dunne JA, Jacobs N, Morrison A, et al. Efficacy in anterior uveitis of two known steroids and topical tolmetin. Br J Ophthalmol. 1985;69:120-125.
45. Young BJ, Cunningham WF, Akingbehin T. Double-masked controlled clinical trial of 5% tolmetin versus 0.5% prednisolone versus 0.9% saline in acute endogenous nongranulomatous anterior uveitis. Br J Ophthalmol. 1982;66:389-391.
46. Olson NY, Lindsley CB, Godfrey WA. Nonsteroidal anti-inflammatory drug therapy in chronic childhood iridocyclitis. Am J Dis Child. 1988;142:1289-1292.
47. Kim SJ, Adams NA, Toma HS, et al. Safety of intravitreal ketorolac and diclofenac: an electroretinographic and histopathologic study. Retina. 2008;28:595-605.
48. Baranano DE, Kim SJ, Edelhauser HF, et al. Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation. Br J Ophthalmol. 2009;93:1387-1390.
49. Kwok AK, Lam DS, Ng JS, et al. Ocular-hypertensive response to topical steroids in children. Ophthalmology. 1997;104:2112-2116.
50. Ng JS, Fan DS, Young AL, et al. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon. Ophthalmology. 2000;107:2097-2100.
51. Fan DS, Yu CB, Chiu TY, et al. Ocular-hypertesnive and anti-inflammatory response to rimexolone therapy in children. Arch Ophthalmol. 2003;121:1716-1721.
52. Chang J, McCluskey PJ, Grigg JR, et al. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular oedema in children. Clin Experiment Ophthalmol. 2006;34:A59-A68.
53. Callanan DG, Jaffe GJ, Martin DF, et al. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol. 2008;126:1191-1201.
54. Malik AR, Pavesio C. The use of low dose methotrexate in children with chronic anterior and intermediate uveitis. Br J Ophthalmol. 2005;89:806-808.
55. Yu EN, Meniconi ME, Tufail F, et al. Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. Ocul Immunol Inflamm. 2005;13:353-360.
56. Gangaputra S, Newcomb CW, Liesegang TL, et al. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116:2188-2198.
57. Doycheva D, Deuter C, Stuebiger N, et al. Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol. 2007;91:180-184.
58. Siepmann K, Huber M, Stubiger N, et al. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis: a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol. 2006;244:788-794.
59. Thorne JE, Jabs DA, Qazi FA, et al. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology. 2005;112:1472-1477.
60. Daniel E, Thorne JE, Newcomb CW, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010;149:423-432.
61. Walton RC, Nussenblatt RB, Whitcup SM. Cyclosporine therapy for severe sightthreatening uveitis in children and adolescents. Ophthalmology. 1998;105:2028-2034.
62. Kilmartin DJ, Forrester JV, Dick AD. Cyclosporin A therapy in refractory noninfectious childhood uveitis. Br J Ophthalmol. 1998;82:737-742.
63. Tappeiner C, Roesel M, Heinz C, et al. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye. 2009;23:1192-1198.
64. Hogan AC, McAvoy CE, Dick AD, et al. Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis. Ophthalmology. 2007;114:1000-1006.
65. Sharma SM, Dick AD, Ramanan AV. Non-infectious pediatric uveitis: an update on immunomodulatory management. Paediatr Drugs. 2009;11:229-241.
66. Cash JM, Klippel JH. Second-line drug therapy for rheumatoid arthritis. N Engl J Med. 1994; 330:1368.
67. Ardoin SP, Kredich D, Rabinovich E, et al. Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up. Am J Ophthalmol. 2007;144:844-849.
68. Foeldvari I, Nielsen S, Kummerle-Deschner J, et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol. 2007;34:1146-1150.
69. Gallagher M, Quinones K, Cervantes-Castaneda RA, et al. Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol. 2007;91:1341-1344.
70. Saurenmann RK, Levin AV, Rose JB, et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford). 2006;45:982-989.
71. Kahn P, Weiss M, Imundo FL, et al. Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology. 2006;113:860-864.
72. Rajaraman RT, Kimura Y, Li S, et al. Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology. 2006;113:308-314.
73. Richards JC, Tay-Kearney M, Murrah K, et al. Infliximab for juvenile idiopathic arthritis-associated uveitis. Clin Experiment Ophthalmol. 2005;33:461-468.
74. Galor A, Perez VL, Hammel JP, et al. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology. 2006;113: 2317-2323.
75. Reiff A, Takei S, Sadeghi S, et al. Etanercept therapy in children with treatmentresistant uveitis. Arthritis Rheum. 2001;44:1411-1415.
76. Tynjala P, Lindahl P, Honkanen V, et al. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis. 2007;66:548-550.
77. Smith JA, Thompson DJ, Whitcup SM, et al. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum. 2005;53:18-23.
78. Tynjala P, Kotaniemi K, Lindahl P, et al. Adalimumab in juvenile idiopathic arthritisassociated chronic anterior uveitis. Rheumatology (Oxford). 2008;47:339-344.
79. Biester S, Deuter C, Michels H, et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol. 2007;91:319-324.
80. Vazquez-Cobian LB, Flynn T, Lehman TJ. Adalimumab therapy for childhood uveitis. J Pediatr. 2006;149:57205.
81. Yeh S, Faia LJ, Nussenblatt RB. Advances in the diagnosis and immunotherapy for ocular inflammatory disease. Semin Immunopathol. 2008;30:145-164.
82. Teoh SC, Sharma S, Hogan A, et al. Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome. Br J Ophthalmol. 2007;91:263-264.
83. Arostegui JI, Arnal C, Merino R, et al. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum. 2007;56:3805-3813.
84. Sobrin L, Huang JJ, Christen W, et al. Daclizumab for treatment of birdshot chorioretinopathy. Arch Ophthalmol. 2008;126:186-191.
85. Yeh S, Wroblewski K, Buggage R, et al. High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for treatment of active, non-infectious uveitis. J Autoimmun. 2008;31:91-97.
86. Bhat P, Castaneda-Cervantes RA, Doctor PP, et al. Intravenous daclizumab for recalcitrant ocular inflammatory disease. Graefes Arch Clin Exp Ophthalmol. 2009;247: 687-692.
87. Sen HN, Levy-Clarke G, Faia LJ, et al. High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis. Am J Ophthalmol. 2009; 148:696-703.
88. Kump LI, Cervantes-Castaneda RA, Androudi SN, et al. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005;112:1287-1292.
89. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN)Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140: 509-516.
90. Lam LA, Lowder CY, Baerveldt G, et al. Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis. Am J Ophthalmol. 2003;135: 772-778.
91. Flynn HJ, Davis JL, Culbertson WW. Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis. Ophthalmology. 1988;95: 1114-1119.
92. Holland GN. Intraocular lens implantation in patients with juvenile rheumatoid arthritis-associated uveitis: an unresolved management issue. Am J Ophthalmol. 1996; 122:255-257.
93. Valimaki J, Airaksinen PJ, Tuulonen A. Molteno implantation for secondary glaucoma in juvenile rheumatoid arthritis. Arch Ophthalmol. 1997;115:1253-1256.
94. Sijssens KM, Rothova A, Berendschot TT, et al. Ocular hypertension and secondary glaucoma in children with uveitis. Ophthalmology. 2006;113:853-859.
95. Belair ML, Kim SJ, Thorne JE, et al. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol. 2009;148:128-135.